1990
DOI: 10.1016/s0196-0644(05)82598-3
|View full text |Cite
|
Sign up to set email alerts
|

Early detection of acute myocardial infarction in patients presenting with chest pain and nondiagnostic ECGs: Serial CK-MB sampling in the emergency department

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

2
54
0
6

Year Published

1998
1998
2023
2023

Publication Types

Select...
5
2
1

Relationship

0
8

Authors

Journals

citations
Cited by 193 publications
(62 citation statements)
references
References 60 publications
2
54
0
6
Order By: Relevance
“…Patients with chest pain of uncertain origin often undergo a period of observation varying from 6 to 12 hours, serial cardiac enzyme sampling, [15][16][17][18][19] ECGs, and possibly provocative stress testing. 20 As many hospitals face situations with decreased inpatient capacity resulting in "bed block," 21 management of chest pain in the ED can possibly decrease in-hospital admissions for evaluation of chest pain.…”
Section: Discussionmentioning
confidence: 99%
“…Patients with chest pain of uncertain origin often undergo a period of observation varying from 6 to 12 hours, serial cardiac enzyme sampling, [15][16][17][18][19] ECGs, and possibly provocative stress testing. 20 As many hospitals face situations with decreased inpatient capacity resulting in "bed block," 21 management of chest pain in the ED can possibly decrease in-hospital admissions for evaluation of chest pain.…”
Section: Discussionmentioning
confidence: 99%
“…Of the two cardiac biomarkers, troponin has slower release than CK-MB; this may result in fewer patients having positive cardiac biomarker tests in the ED. 7,20,21 But this effect is small because the difference between biomarkers is small: 95% sensitivity at 8 hours versus 10 hours of symptoms, and the proportion positive in the ED is low and comparable. 21 The introduction of troponin biomarker assays may identify some patients with myocardial necrosis who were not previously identified: those with elevations in troponin without elevation in CK-MB.…”
Section: Discussionmentioning
confidence: 99%
“…21 The introduction of troponin biomarker assays may identify some patients with myocardial necrosis who were not previously identified: those with elevations in troponin without elevation in CK-MB. 7,20,21 But this effect is small, because both types of cardiac biomarker tests have 95% or greater specificity, 21 and affect AMI discharge diagnosis, not the diagnosis on admission.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…14) Traditional biochemical markers such as CK and CKMB do not have high sensitivity and specificity rates in diagnosing small infarcts and the area under risk. 3,6,[15][16][17][18][19] In addition, cTnT has high sensitivity and specificity rates in the determination of myocardial injury, and a close chimeric relationship has been shown between myocardial destruction and the cTnT released from cells. 5) With these qualifications, in our study, the values of cTnT in the prediction of LV function have been investigated using a rapid bedside assay.…”
Section: Discussionmentioning
confidence: 99%